Why Healthcare GTM Teams Keep Missing the Real Decision Makers
Most healthcare GTM teams still operate on a simple map: hospital equals account, C suite equals decision maker, usage equals authority. That model worked when care delivery was fragmented and decisions were made locally.
It doesn't work anymore.
In 2026, decision authority is distributed across risk bearing physician groups, MSOs, payer owned clinics, health systems, private equity platforms, and referral networks that rarely appear in a CRM hierarchy.
And when deals slow, the real problem usually isn't competition. It is structure. Healthcare didn't become more complex. It became more centralized, just in places most GTM teams aren't looking.
Over the past decade, the structure of the healthcare market has quietly reorganized. From a distance, the number of hospitals and clinics hasn't changed dramatically. But the control layer above them has.
Most GTM strategies still map markets around facilities because those are the most visible parts of the system. But facilities show where care happens, not necessarily where decisions are made.
Hospitals and clinics are the visible infrastructure. But decisions increasingly sit above them, inside payer networks, health systems, MSOs, and physician platforms. When that control layer shifts, the market shifts even if the facilities themselves look unchanged.
That is why sales teams experience a strange pattern when markets evolve. Hospitals are still operating, physicians are still practicing, and yet deals slow. Conversations stall because the decision moved somewhere the sales team never targeted.
Structural shifts rarely appear as obvious disruptions. They show up first as subtle signals that many GTM teams misinterpret.
When sales slow, many teams respond by expanding their target list. Ten hospitals may appear as ten accounts in a CRM. If they belong to the same health system, the real decision point may be one procurement office. The visible market looks large, but the buying power behind it is consolidating.
Most analytics tools track procedure volumes and patient counts. Take ambulatory surgery centers. Procedure volume has shifted rapidly to ASCs, yet many of those centers are owned by health systems or joint ventures that control purchasing decisions across multiple locations. The facility is visible. The decision source is not.
When deals slow down, commercial teams often assume stronger competitors are winning. The reality? The decision moved somewhere else. Procurement teams, MSOs, and platforms control vendor decisions. The team thinks they are speaking to a buyer. They are often speaking to a user.
Once you recognize that healthcare isn't flat, the next question becomes obvious: what should you map instead? Leading GTM teams focus on the structures behind facilities.
Instead of treating healthcare organizations as accounts, smart teams treat them as decision networks.
Treating every location as an independent buyer.
Facilities deliver care. Platforms control decisions.